Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

INVO Fertility (IVF) EBIT Margin (2016 - 2025)

INVO Fertility has reported EBIT Margin over the past 15 years, most recently at 93.08% for Q3 2025.

  • Quarterly EBIT Margin fell 234.0% to 93.08% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 273.36% through Sep 2025, down 17429.0% year-over-year, with the annual reading at 29.24% for FY2024, 19479.0% up from the prior year.
  • EBIT Margin was 93.08% for Q3 2025 at INVO Fertility, up from 160.44% in the prior quarter.
  • Over five years, EBIT Margin peaked at 2051.28% in Q4 2022 and troughed at 1835.17% in Q2 2022.
  • The 5-year median for EBIT Margin is 160.44% (2025), against an average of 394.01%.
  • Year-over-year, EBIT Margin soared 190837bps in 2022 and then plummeted -216045bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 142.91% in 2021, then skyrocketed by 1335bps to 2051.28% in 2022, then crashed by -105bps to 109.17% in 2023, then soared by 249bps to 163.18% in 2024, then crashed by -157bps to 93.08% in 2025.
  • Per Business Quant, the three most recent readings for IVF's EBIT Margin are 93.08% (Q3 2025), 160.44% (Q2 2025), and 1044.93% (Q1 2025).